The Yin and Yang of PDT and PTT.
Journal
Photochemistry and photobiology
ISSN: 1751-1097
Titre abrégé: Photochem Photobiol
Pays: United States
ID NLM: 0376425
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
05
08
2019
accepted:
24
10
2019
pubmed:
27
11
2019
medline:
9
2
2021
entrez:
27
11
2019
Statut:
ppublish
Résumé
In Chinese philosophy, yin and yang ("dark-bright," "negative-positive") describe how seemingly opposite or contrary forces may actually be complementary, interconnected and interdependent. This paper provides this perspective on photodynamic and photothermal therapies, with a focus on the treatment of solid tumors. The relative strengths and weaknesses of each modality, both current and emerging, are considered with respect to the underlying biophysics, the required technologies, the biological effects, their translation into clinical practice and the realized or potential clinical outcomes. For each specific clinical application, one or the other modality may be clearly preferred, or both are effectively equivalent in terms of the various scientific/technological/practical/clinical trade-offs involved. Alternatively, a combination may the best approach. Such combined approaches may be facilitated by the use of multifunctional nanoparticles. It is important to understand the many factors that go into the selection of the optimal approach and the objective of this paper is to provide guidance on this.
Substances chimiques
Photosensitizing Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
219-231Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2019 American Society for Photobiology.
Références
Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson and J. Golab (2011) Photodynamic therapy of cancer: An update. Cancer J. Clin. 61, 250-281.
Dolmans, D., D. Fukumura and R. K. Jain (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387.
Henderson, B. W. and T. J. Dougherty (1992) How does photodynamic therapy work. Photochem. Photobiol. 55, 145-157.
Verteporfin Photodynamic Therapy, S. (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am. J. Ophthalmol. 131, 541-560.
Kato, H. (1998) Photodynamic therapy for lung cancer - a review of 19 years' experience. J. Photochem. Photobiol. B-Biol. 42, 96-99.
Overholt, B. F., K. K. Wang, J. S. Burdick, C. J. Lightdale, M. Kimmey, H. R. Nava, M. V. Sivak, N. Nishioka, H. Barr, N. Marcon, M. Pedrosa, M. R. Bronner, M. Grace and M. Depot (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest. Endosc. 66, 460-468.
Prout, G. R., C. W. Lin, R. Benson, U. O. Nseyo, J. J. Daly, P. P. Griffin, J. Kinsey, M. E. Tian, Y. H. Lao, Y. Z. Mian, X. Chen, F. M. Ren and S. J. Qiao (1987) Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N. Engl. J. Med. 317, 1251-1255.
Kalka, K., H. Merk and H. Mukhtar (2000) Photodynamic therapy in dermatology. J. Am. Acad. Dermatol. 42, 389-413.
Azzouzi, A. R., S. Vincendeau, E. Barret, A. Cicco, F. Kleinclauss, H. G. van der Poel, C. G. Stief, J. Rassweiler, G. Salomon, E. Solsona, A. Alcaraz, T. T. Tammela, D. J. Rosario, F. Gomez-Veiga, G. Ahlgren, F. Benzaghou, B. Gaillac, B. Amzal, F. M. J. Debruyne, G. Fromont, C. Gratzke, M. Emberton and P. C. M. S. Grp (2017) Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): An open-label, phase 3, randomised controlled trial. Lancet Oncol. 18, 181-191.
Christodoulides, N., D. Nikolidakis, P. Chondros, J. Becker, F. Schwarz, R. Rossler and A. Sculean (2008) Photodynamic therapy as an adjunct to non-surgical periodontal treatment: A randomized, controlled clinical trial. J. Periodontol. 79, 1638-1644.
Henderson, B. W., S. M. Waldow, W. R. Potter and T. J. Dougherty (1985) Interaction of photodynamic therapy and hyperthermia - tumor response and cell-survival studies after treatment of mice in vivo. Can. Res. 45, 6071-6077.
Hirschberg, H., C. H. Sun, B. J. Tromberg, A. T. Yeh and S. J. Madsen (2004) Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids. J. Neuro-Oncol. 70, 289-299.
Kelleher, D. K., J. Bastian, O. Thews and P. Vaupel (2003) Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br. J. Cancer 89, 405-411.
Chen, W. R., R. L. Adams, S. Heaton, D. T. Dickey, K. E. Bartels and R. E. Nordquist (1995) Chromophore-enhanced laser-tumor tissue photothermal interaction using an 808-nm diode laser. Cancer Lett. 88, 15-19.
Chitgupi, U., Y. Qin and J. F. Lovell (2017) Targeted nanomaterials for phototherapy. Nanotheranostics 1, 38-58.
Bown, S. G. (1986) Endoscopic laser therapy for oesophageal cancer. Endoscopy 18(Suppl 3), 26-31.
Farrell, T. J., B. C. Wilson, M. S. Patterson and M. C. Olivo (1998) Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model. Photochem. Photobiol. 68, 394-399.
Bisland, S., L. Lilge, A. Lin and B. Wilson (2003) Metronomic photodynamic therapy (mPDT) for intracranial neoplasm: Physiological, biological and dosimetry considerations. In Therapeutic Laser Applications and Laser-Tissue Interactions, Vol. 5142. (Edited by R. Steiner), paper 5142_9. Optical Society of America, Proceedings of Society of Photo-Optical Instrumentation Engineers.
Cheng, H. L. M., M. A. Haider, M. J. Dill-Macky, J. M. Sweet, J. Trachtenberg and M. R. Gertner (2008) MRI and contrast-enhanced ultrasound monitoring of prostate microwave focal thermal therapy: An in vivo canine study. J. Magn. Reson. Imaging 28, 136-143.
Goldberg, S. N., G. S. Gazelle and P. R. Mueller (2000) Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am. J. Roentgenol. 174, 323-331.
Patel, P., N. V. Patel and S. F. Danish (2016) Intracranial MR-guided laser-induced thermal therapy: Single-center experience with the Visualase thermal therapy system. J. Neurosurg. 125, 853-860.
Sloan, A. E., M. S. Ahluwalia, J. Valerio-Pascua, S. Manjila, M. G. Torchia, S. E. Jones, J. L. Sunshine, M. Phillips, M. A. Griswold, M. Clampitt, C. Brewer, J. Jochum, M. V. McGraw, D. Diorio, G. Ditz and G. H. Barnett (2013) Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma Clinical article. J. Neurosurg. 118, 1202-1219.
Mahmoudi, K., K. L. Garvey, A. Bouras, G. Cramer, H. Stepp, J. G. J. Raj, D. Bozec, T. M. Busch and C. G. Hadjipanayis (2019) 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. J. Neuro-Oncol. 141, 595-607.
Trachtenberg, J., A. Bogaards, R. A. Weersink, M. A. Haider, A. Evans, S. A. McCluskey, A. Scherz, M. R. Gertner, C. Yue, S. Appu, A. Aprikian, J. Savard, B. C. Wilson and M. Elhilali (2007) Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: Assessment of safety and treatment response. J. Urol. 178, 1974-1979.
Davidson, S. R. H., R. A. Weersink, M. A. Haider, M. R. Gertner, A. Bogaards, D. Giewercer, A. Scherz, M. D. Sherar, M. Elhilali, J. L. Chin, J. Trachtenberg and B. C. Wilson (2009) Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys. Med. Biol. 54, 2293-2313.
Swartling, J., J. Axelsson, G. Ahlgren, K. M. Kalkner, S. Nilsson, S. Svanberg, K. Svanberg and S. Andersson-Engels (2010) System for interstitial photodynamic therapy with online dosimetry: First clinical experiences of prostate cancer. J. Biomed. Optics 15(5), 058003.
Zhu, T. C. and J. C. Finlay (2006) Prostate PDT dosimetry. Photodiagnosis Photodyn. Ther. 3, 234-246.
Kannadorai, R. K. and Q. Liu (2013) Optimization in interstitial plasmonic photothermal therapy for treatment planning. Med. Phys. 40(10), 103301.
Puccini, S., N. K. Bar, M. Bublat, T. Kahn and H. Busse (2003) Simulations of thermal tissue coagulation and their value for the planning and monitoring of laser-induced interstitial thermotherapy (LITT). Magn. Reson. Med. 49, 351-362.
Kim, M. M., R. Penjweini and T. C. Zhu (2017) Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy. J. Biomed. Optics 22.
Li, C. L., C. J. Fisher, R. B. Shi, B. C. Wilson, J. He, G. Zheng and R. A.Weersink (2019) Pre-clinical validation of transrectal diffuse optical tomography for monitoring photocoagulation progression during photothermal therapy of prostate cancer. In Multimodal Biomedical Imaging XVI, Vol. 10871. (Edited by F. S. Azar, X. Intes and Q. Fang), 1087115. Proceedings of Society of Photo-Optical Instrumentation Engineers, 27 February 2019. https://doi.org/10.1117/12.2509059
Patel, N. V., K. Frenchu and S. F. Danish (2018) Does the thermal damage estimate correlate with the magnetic resonance imaging-predicted ablation size after laser interstitial thermal therapy? Operat. Neurosurg. 15, 179-183.
Raz, O., M. A. Haider, S. R. H. Davidson, U. Lindner, E. Hlasny, R. Weersink, M. R. Gertner, W. Kucharcyzk, S. A. McCluskey and J. Trachtenberg (2010) Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur. Urol. 58, 173-177.
Atri, M., M. R. Gertner, M. A. Haider, R. A. Weersink and J. Trachtenberg (2009) Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. Cuaj-Canadian Urol. Assoc. J. 3, 125-130.
Ashrafi, A. N., N. Nassiri, I. S. Gill, M. Gulati, D. Park and A. de Castro Abreu (2018) Contrast-enhanced transrectal ultrasound in focal therapy for prostate cancer. Curr. Urol. Rep. 19(10).
Lindner, U., N. Lawrentschuk, R. A. Weersink, S. R. Davidson, O. Raz, E. Hlasny, D. L. Langer, M. R. Gertner, T. Van der Kwast, M. A. Haider and J. Trachtenberg (2010) Focal laser ablation for prostate cancer followed by radical prostatectomy: Validation of focal therapy and imaging accuracy. Eur. Urol. 57, 1111-1114.
Haider, M. A., S. R. H. Davidson, A. V. Kale, R. A. Weersink, A. J. Evans, A. Toi, M. R. Gertner, A. Bogaards, B. C. Wilson, J. L. Chin, M. Elhilali and J. Trachtenberg (2007) Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology 244, 196-204.
Trachtenberg, J., R. A. Weersink, S. R. H. Davidson, M. A. Haider, A. Bogaards, M. R. Gertner, A. Evans, A. Scherz, J. Savard, J. L. Chin, B. C. Wilson and M. Elhilali (2008) Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: A study of escalating light doses. BJU Int. 102, 556-562.
Betrouni, N., S. Boukris and F. Benzaghou (2017) Vascular targeted photodynamic therapy with TOOKAD (R) Soluble (WST11) in localized prostate cancer: Efficiency of automatic pre-treatment planning. Lasers Med. Sci. 32, 1301-1307.
Betrouni, N., R. Lopes, P. Puech, P. Colin and S. Mordon (2011) A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD Soluble WST11. Phys. Med. Biol. 56, 4771-4783.
Glassberg, M. B., S. Ghosh, J. W. Clymer, R. A. Qadeer, N. C. Ferko, B. Sadeghirad, G. W. J. Wright and J. F. Amaral (2019) Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: A systematic review and meta-analysis. OncoTargets Ther. 12, 6407-6438.
Maloney, E. and J. H. Hwang (2015) Emerging HIFU applications in cancer therapy. Int. J. Hyperthermia 31, 302-309.
Prud'homme, C., F. Deschamps, B. Moulin, A. Hakime, M. Al-Ahmar, S. Moalla, C. Roux, C. Teriitehau, T. de Baere and L. Tselikas (2019) Image-guided lung metastasis ablation: A literature review. Int. J. Hyperthermia 36, 37-45.
Barr, H., C. J. Tralau, P. B. Boulos, A. J. Macrobert, R. Tilly and S. G. Bown (1987) The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal-injury. Photochem. Photobiol. 46, 795-800.
Lou, P. J., H. R. Jager, L. Jones, T. Theodossy, S. G. Bown and C. Hopper (2004) Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br. J. Cancer 91, 441-446.
Ang, J. M., I. Bin Riaz, M. U. Kamal, G. Paragh and N. C. Zeitouni (2017) Photodynamic therapy and pain: A systematic review. Photodiagnosis Photodyn. Ther. 19, 308-344.
Thong, P. S. R., M. Olivo, K. W. Kho, R. Bhuvaneswari, W. W. L. Chin, K. W. Ong and K. C. Soo (2007) Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. J. Environ. Pathol. Toxicol. Oncol. 27, 35-42.
Korbelik, M. and M. R. Hamblin (2015) The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy. Photochem. Photobiol. Sci. 14, 1403-1409.
Ivarsson, K., L. Myllymaki, K. Jansner, U. Stenram and K. G. Tranberg (2005) Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. Br. J. Cancer 93, 435-440.
Tracz, R. A., D. R. Wyman, P. B. Little, R. A. Towner, W. A. Stewart, S. W. Schatz, P. W. Pennock and B. C. Wilson (1992) Magnetic-resonance-imaging of interstitial laser photocoagulation in brain. Lasers Surg. Med. 12, 165-173.
Muller, P. J. and B. C. Wilson (1987) Photodynamic therapy of malignant primary brain-tumors - clinical effects, postoperative ICP, and light penetration of the brain. Photochem. Photobiol. 46, 929-935.
Reginato, E., P. Wolf and H.Hamblin (2014) Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J. Immunol. 4, 1-11.
Nam, J., S. Son, K. S. Park, W. P. Zou, L. D. Shea and J. J. Moon (2019) Cancer nanomedicine for combination cancer immunotherapy. Nat. Rev. Mater. 4, 398-414.
Ibbotson, S. (2018) Drug and chemical induced photosensitivity from a clinical perspective. Photochem. Photobiol. Sci. 17, 1885-1903.
Munier, S. M., E. L. Hargreaves, N. V. Patel and S. F. Danish (2018) Effects of variable power on tissue ablation dynamics during magnetic resonance-guided laser-induced thermal therapy with the Visualase system. Int. J. Hyperthermia 34, 764-772.
Ahluwalia, M., G. H. Barnett, D. Deng, S. B. Tatter, A. W. Laxton, A. M. Mohammadi, E. Leuthardt, R. Chamoun, K. Judy, A. Asher, M. Essig, J. Dietrich and V. L. Chiang (2019) Laser ablation after stereotactic radiosurgery: A multicenter prospective study in patients with metastatic brain tumors and radiation necrosis. J. Neurosurg. 130, 804-811.
Carpentier, A., R. J. McNichols, R. J. Stafford, J. Itzcovitz, J. P. Guichard, D. Reizine, S. Delaloge, E. Vicaut, D. Payen, A. Gowda and B. George (2008) Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors. Neurosurgery 63, 21-28.
Jethwa, P. R., J. C. Barrese, A. Gowda, A. Shetty and S. F. Danish (2012) Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: Initial experience. Neurosurgery 71, 133-144.
Quirk, B. J., G. Brandal, S. Donlon, J. C. Vera, T. S. Mang, A. B. Foy, S. M. Lew, A. W. Girotti, S. Jogal, P. S. LaViolette, J. M. Connelly and H. T. Whelan (2015) Photodynamic therapy (PDT) for malignant brain tumors Where do we stand? Photodiagnosis Photodyn. Ther. 12, 530-544.
Muller, P. J. and B. C. Wilson (1995) Photodynamic therapy for recurrent supratentorial gliomas. Semin. Surg. Oncol. 11, 346-354.
Akimoto, J., J. Haraoka and K. Aizawa (2012) Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. Photodiagnosis Photodyn. Ther. 9, 91-99.
Muragaki, Y., J. Akimoto, T. Maruyama, H. Iseki, S. Ikuta, M. Nitta, K. Maebayashi, T. Saito, Y. Okada, S. Kaneko, A. Matsumura, T. Kuroiwa, K. Karasawa, Y. Nakazato and T. Kayama (2013) Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors Clinical article. J. Neurosurg. 119, 845-852.
Muller, P. J. and B. C. Wilson (2006) Photodynamic therapy of brain tumors - a work in progress. Lasers Surg. Med. 38, 384-389.
Rosenthal, M. A., B. Kavar, J. S. Hill, D. J. Morgan, R. L. Nation, S. S. Stylli, R. L. Basser, S. Uren, H. Geldard, M. D. Green, S. B. Kahl and A. H. Kaye (2001) Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J. Clin. Oncol. 19, 519-524.
Schmidt, M. H., D. M. Bajic, K. W. Reichert, T. S. Martin, G. A. Meyer and H. T. Whelan (1996) Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery 38, 552-556.
Stepp, H. and W. Stummer (2018) 5-ALA in the management of malignant glioma. Lasers Surg. Med. 50, 399-419.
Beck, T. J., F. W. Kreth, W. Beyer, J. H. Mehrkens, A. Obermeier, H. Stepp, W. Stummer and R. Baumgartner (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg. Med. 39, 386-393.
Kostron, H. (2010) Photodynamic diagnosis and therapy and the brain. In Photodynamic Therapy: Methods and Protocols, Vol. 635. (Edited by C. J. Gomer), pp. 261-280. Humana Press, Totowa, NJ, USA.
Yang, V. X. D., P. J. Muller, P. Herman and B. C. Wilson (2003) A multispectral fluorescence imaging system: Design and initial clinic tests in intra-operative photofrin-photodynamic therapy of brain tumors. Lasers Surg. Med. 32, 224-232.
Stummer, W., U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella and H.-J. Reulen (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol. 7, 392-401.
Hadjipanayis, C. G. and W. Stummer (2019) 5-ALA and FDA approval for glioma surgery. J. Neuro-Oncol. 141, 479-486.
Nathan, T. R., D. E. Whitelaw, S. C. Chang, W. R. Lees, P. M. Ripley, H. Payne, L. Jones, M. C. Parkinson, M. Emberton, A. R. Gillams, A. R. Mundy and S. G. Bown (2002) Photodynamic therapy for prostate cancer recurrence after radiotherapy: A phase I study. J. Urol. 168, 1427-1432.
Moore, C. M., T. R. Nathan, W. R. Lees, C. A. Mosse, A. Freeman, M. Emberton and S. G. Bown (2006) Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg. Med. 38, 356-363.
Li, J. and T. C. Zhu (2008) Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy. Phys. Med. Biol. 53, 2103-2114.
Weersink, R. A., A. Bogaards, M. Gertner, S. R. H. Davidson, K. Zhang, G. Netchev, J. Trachtenberg and B. C. Wilson (2005) Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: Clinical experience and practicalities. J. Photochem. Photobiol. B-Biol. 79, 211-222.
Azzouzi, A. R., E. Barret, C. M. Moore, A. Villers, C. Allen, A. Scherz, G. Muir, M. de Wildt, N. J. Barber, S. Lebdai and M. Emberton (2013) TOOKAD((R)) Soluble vascular-targeted photodynamic (VTP) therapy: Determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. BJU Int. 112, 766-774.
Johnson, D. E., D. M. Cromeens and R. E. Price (1994) Interstitial laser prostatectomy. Lasers Surg. Med. 14, 299-305.
Natarajan, S., T. A. Jones, A. M. Priester, R. Geoghegan, P. Lieu, M. Delfin, E. Felker, D. J. A. Margolis, A. Sisk, A. Pantuck, W. Grundfest and L. S. Marks (2017) Focal laser ablation of prostate cancer: Feasibility of magnetic resonance imaging-ultrasound fusion for guidance. J. Urol. 198, 839-846.
Walser, E., A. Nance, L. Ynalvez, S. Yong, J. S. Aoughsten, E. J. Eyzaguirre and S. B. Williams (2019) Focal laser ablation of prostate cancer: Results in 120 patients with low- to intermediate-risk disease. J. Vasc. Interv. Radiol. 30, 401-409.
Lindner, U., R. A. Weersink, M. A. Haider, M. R. Gertner, S. R. H. Davidson, M. Atri, B. C. Wilson, A. Fenster and J. Trachtenberg (2009) Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J. Urol. 182, 1371-1377.
Yao, C. P., L. W. Zhang, J. Wang, Y. L. He, J. Xin, S. J. Wang, H. Xu and Z. X. Zhang (2016) Gold nanoparticle mediated phototherapy for cancer. J. Nanomater. 2016, 1-29.
Kotagiri, N., G. P. Sudlow, W. J. Akers and S. Achilefu (2015) Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat. Nanotechnol. 10, 370-379.
Vines, J. B., J. H. Yvon, N. E. Ryu, D. J. Lim and H. Park (2019) Gold nanoparticles for photothermal cancer therapy. Frontiers in Chemistry 7.
Fu, Q. R., R. Zhu, J. B. Song, H. H. Yang and X. Y. Chen (2019) Photoacoustic imaging: Contrast agents and their biomedical applications. Adv Mater 31.
Huynh, E. and G. Zheng (2014) Porphysome nanotechnology: A paradigm shift in lipid-based supramolecular structures. Nano Today 9, 212-222.
Pogue, B. W., E. L. Rosenthal, S. Achilefu and G. M. van Dam (2018) Perspective review of what is needed for molecular-specific fluorescence-guided surgery. J. Biomed. Optics 23.
Niedre, M., M. S. Patterson and B. C. Wilson (2002) Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol. 75, 382-391.
Lukač, M., A. Lozar, T. Perhavec and F. Bajd (2019) Variable heat shock response model for medical laser procedures. Lasers Med. Sci. 34, 1147-1158.